Correlation Between Apellis Pharmaceuticals and Fate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Apellis Pharmaceuticals and Fate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apellis Pharmaceuticals and Fate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apellis Pharmaceuticals and Fate Therapeutics, you can compare the effects of market volatilities on Apellis Pharmaceuticals and Fate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apellis Pharmaceuticals with a short position of Fate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apellis Pharmaceuticals and Fate Therapeutics.
Diversification Opportunities for Apellis Pharmaceuticals and Fate Therapeutics
0.56 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Apellis and Fate is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and Fate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fate Therapeutics and Apellis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apellis Pharmaceuticals are associated (or correlated) with Fate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fate Therapeutics has no effect on the direction of Apellis Pharmaceuticals i.e., Apellis Pharmaceuticals and Fate Therapeutics go up and down completely randomly.
Pair Corralation between Apellis Pharmaceuticals and Fate Therapeutics
Given the investment horizon of 90 days Apellis Pharmaceuticals is expected to under-perform the Fate Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Apellis Pharmaceuticals is 2.67 times less risky than Fate Therapeutics. The stock trades about -0.16 of its potential returns per unit of risk. The Fate Therapeutics is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 137.00 in Fate Therapeutics on November 27, 2024 and sell it today you would lose (1.00) from holding Fate Therapeutics or give up 0.73% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Apellis Pharmaceuticals vs. Fate Therapeutics
Performance |
| Timeline |
| Apellis Pharmaceuticals |
| Fate Therapeutics |
Apellis Pharmaceuticals and Fate Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apellis Pharmaceuticals and Fate Therapeutics
The main advantage of trading using opposite Apellis Pharmaceuticals and Fate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apellis Pharmaceuticals position performs unexpectedly, Fate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fate Therapeutics will offset losses from the drop in Fate Therapeutics' long position.| Apellis Pharmaceuticals vs. Akero Therapeutics | Apellis Pharmaceuticals vs. Immunovant | Apellis Pharmaceuticals vs. Madrigal Pharmaceuticals | Apellis Pharmaceuticals vs. Day One Biopharmaceuticals |
| Fate Therapeutics vs. Atara Biotherapeutics | Fate Therapeutics vs. Sana Biotechnology | Fate Therapeutics vs. Caribou Biosciences | Fate Therapeutics vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Stocks Directory Find actively traded stocks across global markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |